Table 1. Mycobacterium abscessus antibiotic susceptibilities for case-patient who underwent intrathecal stem cell injections as treatment for multiple sclerosis at a clinic in Mexico*.
| Antimicrobial | MIC, μg/mL | Interpretation |
|---|---|---|
| Amikacin | 64 | Resistant |
| Cefoxitin | 32 | Intermediate |
| Ciprofloxacin | ≥8 | Resistant |
| Clarithromycin | 1 | Susceptible |
| Doxycycline | ≥16 | Resistant |
| Imipenem | 16 | Intermediate |
| Linezolid | 8 | Susceptible |
| Moxifloxacin | ≥8 | Resistant |
| Tigecycline | ≥8 | Resistant |
| Trimethoprim/sulfamethoxazole | ≥8/152 | Resistant |
*Determined by using Clinical and Laboratory Standards Institute cutpoints for resistance (7). There is no recommended cutpoint for tigecycline.